| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 49 | 3.452 | 8.800 | 12.352 | 15.053 | 20.983 | 23.690 |
| Total Income - EUR | - | - | - | 49 | 3.453 | 8.966 | 12.352 | 15.054 | 21.027 | 23.690 |
| Total Expenses - EUR | - | - | - | 6 | 2.076 | 16.847 | 7.128 | 7.220 | 13.412 | 17.771 |
| Gross Profit/Loss - EUR | - | - | - | 42 | 1.377 | -7.881 | 5.224 | 7.834 | 7.615 | 5.920 |
| Net Profit/Loss - EUR | - | - | - | 41 | 1.273 | -8.136 | 4.854 | 7.424 | 6.261 | 4.886 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medical Skin Control S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 432 | 225 | 1.902 | 1.610 |
| Current Assets | - | - | - | 107 | 2.575 | 1.827 | 1.015 | 6.442 | 5.966 | 4.780 |
| Inventories | - | - | - | 0 | 88 | 284 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 303 | 2.028 | 0 | 613 |
| Cash | - | - | - | 107 | 2.487 | 1.543 | 712 | 4.414 | 5.966 | 4.167 |
| Shareholders Funds | - | - | - | 84 | 1.355 | -6.806 | -1.801 | 5.617 | 6.309 | 5.833 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 23 | 1.219 | 8.633 | 3.248 | 1.050 | 1.559 | 557 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medical Skin Control S.r.l.